GRI Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	0	0	0	0.1	0	0
Gross Profit	0	0	0	0.1	0	0
Selling, General & Admin	8.16	2	4.07	1.18	1.27	0.8
Research & Development	3.23	0.24	5.19	3.71	1.88	3.51
Operating Expenses	11.39	2.24	9.26	4.89	3.15	4.31
Operating Income	-11.39	-2.24	-9.26	-4.79	-3.15	-4.31
Interest Expense / Income	2.08	0.65	0.02	0.03	0.2	-0
Other Expense / Income	-0.43	0.33	0.03	-	0.11	-
Pretax Income	-13.04	-3.22	-9.3	-4.82	-3.46	-4.31
Net Income	-13.04	-3.22	-9.3	-4.82	-3.46	-4.31
Shares Outstanding (Basic)	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0
Shares Change	257.82%	314.13%	45.16%	26.93%	121.66%	-
EPS (Basic)	-28.25	-24.95	-298.20	-224.70	-205.80	-588.01
EPS (Diluted)	-28.25	-24.95	-298.20	-224.70	-205.80	-588.01
Free Cash Flow	-9	-1.09	-8.31	-3.71	-2.88	-2.37
Free Cash Flow Per Share	-19.50	-8.44	-266.86	-172.80	-170.59	-311.16
Gross Margin	-	-	-	100.00%	-	-
Operating Margin	-	-	-	-4788.00%	-	-
Profit Margin	-	-	-	-4822.00%	-	-
Free Cash Flow Margin	-	-	-	-3708.00%	-	-
EBITDA	-10.95	-2.56	-9.21	-4.71	-3.25	-4.31
EBITDA Margin	-	-	-	-4714.00%	-	-
Depreciation & Amortization	0	0	0.07	0.07	0.02	0
EBIT	-10.96	-2.56	-9.29	-4.79	-3.27	-4.31
EBIT Margin	-	-	-	-4788.00%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).